中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 12
Dec.  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(12): 2819-2823

Value of FibroScan and platelet count-to-spleen thickness ratio in predicting the degree of esophageal and gastric varices in liver cirrhosis

DOI: 10.3969/j.issn.1001-5256.2021.12.018

  • Department of Gastroenterology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China

Research funding:

Wang Baoen Liver Fibrosis Research Foundation of China Hepatitis Prevention Foundation (2020006)

  • Received Date: 2021-05-29
  • Accepted Date: 2021-07-07
  • Published Date: 2021-12-20
    Abstract
  •   Objective  To investigate the value of transient elastography (FibroScan) and platelet count-to-spleen thickness (PC/ST) ratio in predicting the degree of esophageal and gastric varices (EGV) in liver cirrhosis.  Methods  A total of 210 patients with liver cirrhosis who underwent FibroScan, color Doppler ultrasound, electronic gastroscopy, and blood biochemical examination within three days after admission to The Fifth Affiliated Hospital of Zhengzhou University from January 2017 to September 2020 were enrolled, and according to the "gold standard" of gastroscopy, the patients were divided into none, mild, moderate, and severe EGV groups. A one-way analysis of variance or the Kruskal-Wallis H test were used for comparison of continuous data between multiple groups. Receiver operating characteristic (ROC) curves were plotted for liver stiffness measurement (LSM), PC/ST ratio, and LSM+PC/ST, and the diagnostic performance of these ROC curves was compared using the Delong method.  Results  There were significant differences between the none, mild, moderate, and severe EGV groups in LSM (F=32.00, P < 0.01) and PC/ST ratio (H=49.58, P < 0.01). For the mild EGV group, LSM, PC/ST ratio, and LSM+PC/ST had an area under the ROC curve (AUC) of 0.762, 0.656, and 0.770, respectively, with a positive predictive value of 75.4%, 60.2%, and 82.5%, respectively, and a negative predictive value of 75.0%, 75.8%, and 65.4%, respectively. For the moderate EGV group, LSM, PC/ST ratio, and LSM+PC/ST had an AUC of 0.841, 0.796, and 0.896, respectively, with a positive predictive value of 86.1%, 68.0%, and 74.1%, respectively, and a negative predictive value of 79.7%, 80.5%, and 90.2%, respectively. For the severe EGV group, LSM, PC/ST ratio, and LSM+PC/ST had an AUC of 0.834, 0.830, and 0.903, respectively, with a positive predictive value of 80.5%, 71.4%, and 79.5%, respectively, and a negative predictive value of 82.5%, 83.6%, and 85.0%, respectively. PC/ST ratio and LSM+PC/ST had significantly different AUC in predicting mild, moderate, and severe EGV (Z=2.66, P=0.007; Z=2.71, P=0.007; Z=2.37, P=0.018).  Conclusion  LSM, PC/ST ratio, and LSM+PC/ST have a good predictive value for moderate-to-severe EGV in liver cirrhosis.

     

    • FullText(HTML)
  • loading
    • References(19)
  • [1]
    de FRANCHIS R. Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension[J]. J Hepatol, 2010, 53(4): 762-768. DOI: 10.1016/j.jhep.2010.06.004.
    [2]
    de FRANCHIS R, DELL'ERA A. Invasive and noninvasive methods to diagnose portal hypertension and esophageal varices[J]. Clin Liver Dis, 2014, 18(2): 293-302. DOI: 10.1016/j.cld.2013.12.002.
    [3]
    ZHANG F, LIU T, GAO P, et al. Predictive value of a noninvasive serological hepatic fibrosis scoring system in cirrhosis combined with oesophageal varices[J]. Can J Gastroenterol Hepatol, 2018, 2018: 7671508. DOI: 10.1155/2018/7671508.
    [4]
    DUAH A, NKRUMAH KN, TACHI K. Non-invasive markers as predictors of oesophageal varices in cirrhotic patient in a teaching hospital in Ghana[J]. Ghana Med J, 2019, 53(2): 142-149. DOI: 10.4314/gmj.v53i2.9.
    [5]
    LI N, ZHENG SQ, ZHAO SS. Application of FibroScan, APRI, FIB-4 and GPR in prediction of esophageal varices in patients with liver cirrhosis[J]. J Pract Hepatol, 2020, 23(4): 560-563. DOI: 10.3969/j.issn.1672-5069.2020.04.027.

    李娜, 郑少秋, 赵守松. FibroScan联合多种预测模型预测肝硬化患者食管静脉曲张程度应用价值探讨[J]. 实用肝脏病杂志, 2020, 23(4): 560-563. DOI: 10.3969/j.issn.1672-5069.2020.04.027.
    [6]
    Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Endoscopy, Chinese Medical Association. Guidelines for the diagnosis and treatment of esophageal and gastric variceal bleeding in cirrhotic portal hypertension[J]. J Clin Hepatol, 2016, 32(2): 203-219. DOI: 10.3969/j.issn.1001-5256.2016.02.002.

    中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会内镜学分会. 肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J]. 临床肝胆病杂志, 2016, 32(2): 203-219. DOI: 10.3969/j.issn.1001-5256.2016.02.002.
    [7]
    YU YC, HOU JL. Recommendations for the use of transient elastography in chronic viral hepatitis: Introduction to the Australian Liver Association expert consensus in 2014[J]. J Clin Hepatol, 2015, 31(4): 490-494. DOI: 10.3969/J.issn.1001-5256.2015.04.004.

    于乐成, 侯金林. 《2014年澳大利亚肝病学会专家共识: 瞬时弹性成像在慢性病毒性肝炎中的应用建议》简介[J]. 临床肝胆病杂志, 2015, 31(4): 490-494. DOI: 10.3969/j.issn.1001-5256.2015.04.004.
    [8]
    CASTÉRA L, VERGNIOL J, FOUCHER J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C[J]. Gastroenterology, 2005, 128(2): 343-350. DOI: 10.1053/j.gastro.2004.11.018.
    [9]
    WANG S, ZHANG W, ZHANG F, et al. Correlation between FibroScan, APRI detecting the degree of esophageal and gastric varices of liver cirrhosis[J]. Chin J Hepatol, 2018, 26(5): 342-346. DOI: 10.3760/cma.j.issn.1007-3418.2018.05.006.

    王帅, 张威, 张帆, 等. FibroScan和APRI对肝硬化食管胃底静脉曲张程度的预测价值[J]. 中华肝脏病杂志, 2018, 26(5): 342-346. DOI: 10.3760/cma.j.issn.1007-3418.2018.05.006.
    [10]
    KEW GS, CHEN ZJ, YIP AW, et al. Identifying patients with cirrhosis who might avoid screening endoscopy based on serum albumin and bilirubin and platelet counts[J]. Clin Gastroenterol Hepatol, 2021, 19(1): 199-201. e2. DOI: 10.1016/j.cgh.2019.11.015.
    [11]
    BERGER A, RAVAIOLI F, FARCAU O, et al. Including ratio of platelets to liver stiffness improves accuracy of screening for esophageal varices that require treatment[J]. Clin Gastroenterol Hepatol, 2021, 19(4): 777-787. e17. DOI: 10.1016/j.cgh.2020.06.022.
    [12]
    YANG LB, XU JY, TANTAI XX, et al. Non-invasive prediction model for high-risk esophageal varices in the Chinese population[J]. World J Gastroenterol, 2020, 26(21): 2839-2851. DOI: 10.3748/wjg.v26.i21.2839.
    [13]
    KARATZAS A, KONSTANTAKIS C, AGGELETOPOULOU I, et al. Non-invasive screening for esophageal varices in patients with liver cirrhosis[J]. Ann Gastroenterol, 2018, 31(3): 305-314. DOI: 10.20524/aog.2018.0241.
    [14]
    SAMI SS, HARMAN D, RAGUNATH K, et al. Non-invasive tests for the detection of oesophageal varices in compensated cirrhosis: Systematic review and meta-analysis[J]. United European Gastroenterol J, 2018, 6(6): 806-818. DOI: 10.1177/2050640618767604.
    [15]
    SINGH S, MUIR AJ, DIETERICH DT, et al. American Gastroenterological Association institute technical review on the role of elastography in chronic liver diseases[J]. Gastroenterology, 2017, 152(6): 1544-1577. DOI: 10.1053/j.gastro.2017.03.016.
    [16]
    KIM BK, HAN KH, PARK JY, et al. A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis[J]. Am J Gastroenterol, 2010, 105(6): 1382-1390. DOI: 10.1038/ajg.2009.750.
    [17]
    ZHANG X, GUO Y, YANG J. Evaluation ofesophageal and gastric varices by liver and splenic stiffness measurement by elastography in patients with hepatitis B liver cirrhosis[J]. J Pract Hepatol, 2021, 24(1): 95-98. DOI: 10.3969/j.issn.1672-5069.2021.01.025.

    张昕, 郭悦, 杨军. 瞬时弹性成像测定肝脾硬度值评估乙型肝炎肝硬化患者食管静脉曲张初步研究[J]. 实用肝脏病杂志, 2021, 24(1): 95-98. DOI: 10.3969/j.issn.1672-5069.2021.01.025.
    [18]
    LIN XY, HU XM, CHEN YP. Value of noninvasive liver fibrosis markers in predicting high-risk gastroesophageal varices in patients with liver cirrhosis[J]. J Clin Hepatol, 2020, 36(8): 1742-1746. DOI: 10.3969/j.issn.1001-5256.2020.08.013.

    林小钰, 胡晓敏, 陈永鹏. 无创肝纤维化指标对肝硬化患者高风险胃食管静脉曲张的预测价值[J]. 临床肝胆病杂志, 2020, 36(8): 1742-1746. DOI: 10.3969/j.issn.1001-5256.2020.08.013.
    [19]
    HAN Y, LIU YM, LIAO HY, et al. Non-invasive diagnostic indicators for predicting esophagealgastric varices in patients with hepatitis B-related cirrhosis[J]. Chin J Hepatol, 2012, 20(2): 141-143. DOI: 10.3760/cma.j.issn.1007-3418.2012.02.016.

    韩莹, 刘燕敏, 廖慧钰, 等. 无创伤诊断指标对乙型肝炎肝硬化患者伴食管胃底静脉曲张风险的评估[J]. 中华肝脏病杂志, 2012, 20(2): 141-143. DOI: 10.3760/cma.j.issn.1007-3418.2012.02.016.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (515) PDF downloads(61) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return